glp-1 for migraine Study finds GLP-1 drug cut migraine frequency by nearly half

The FDA has warned six online companies for selling compounded retatrutide, an unlicensed weight-loss drug that has gained traction among social media influencers., "All of a sudden, you have

26.94

★★★★☆4.8 (126)

FDA Warning Letter Breakdown: Sterility Failures, Subpotent GLP-1 Drugs, and a Compounding Pharmacy Operating Without Control

26.56

★★★★★4.9 (98)

Beyond the Headlines: FDA Warning Letters to GLP-1 Compounders

26.07

★★★★★5.0 (157)

FDA issued 30 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. This marks the second round of enforcement action since the agency's September crackdown on misleading

29.88

★★★★★4.7 (84)

The New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed 'fastest growing company in history.'

23.56

★★★★★4.9 (203)

The FDA has sent 30 warning letters to telehealth companies for falsely marketing compounded GLP-1s, which are not FDA-approved and can pose risks to patients. FULL STORY:🔗https://tinyurl.com/3ztf9uj2

29.32

★★★★★5.0 (176)

Today, the FDA established a “green list” import alert to help stop potentially dangerous GLP-1 active pharmaceutical ingredients from unverified foreign sources from entering the U.S. market. The agency will continue to

22.73

★★★★★4.8 (132)